SEIKAGAKU CORPORATION

Seikagaku Corporation is a leading Japanese biotechnology company specializing in advanced therapies for musculoskeletal conditions, particularly osteoarthritis. Renowned for their expertise in glycosaminoglycan biochemistry, they focus on delivering high-quality pharmaceuticals and medical devices to improve global health. The company is best known for creating Supartz, an injectable treatment using highly purified hyaluronan to relieve knee osteoarthritis pain and stiffness.

Brands: Supartz